Invox

invoX aims to improve lives through the delivery of medicines. Our vision is to be a leading developer, manufacturer and supplier of complex respiratory drug-device combination and medicinal products to patients. We have a diversified pipeline of promising clinical and pre-clinical stage drug candidates in respiratory therapeutics. We have developed innovative and generic drug-device combination products using a proprietary next-generation soft mist inhaler (SMI) platform, called Softhaler®. Softhaler® uses differentiated technology to deliver propellant-free liquid-based formulation to the lung.